EV/EBITDA
-1.03
+0.04+3.74%
30 min ago
Summary
- As of February 7, 2025, ABOS EV/EBITDA is -1.03, with a rise of +0.04 (+3.74%) during the most recent trading day.
- Over the past year, ABOS EV/EBITDA has increased by +1.92 (+65.08%).
- ABOS EV/EBITDA is now -347.83% below its all-time high of -0.23.
Performance
ABOS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ABOS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.7% | -2.9% | -2.7% |
| 1 m1 month | +23.1% | -22.5% | -21.6% |
| 3 m3 months | +58.0% | -57.7% | -56.3% |
| 6 m6 months | +48.8% | -31.5% | -45.8% |
| ytdytd | +17.6% | -17.3% | -16.5% |
| 1 y1 year | +65.1% | -47.0% | -56.8% |
| 5 y5 years | - | - | - |
ABOS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.0% | -1.34 | +23.1% | |
| 3 m | 3-month | -1.02 | -1.0% | -2.45 | +58.0% |
| 6 m | 6-month | -1.02 | -1.0% | -2.45 | +58.0% |
| 1 y | 1-year | -1.02 | -1.0% | -4.39 | +76.5% |
| 3 y | 3-year | -0.23 | -347.8% | -10.14 | +89.8% |
| 5 y | 5-year | -0.23 | -347.8% | -67.08 | +98.5% |
| alltime | all time | -0.23 | -347.8% | -67.08 | +98.5% |
Acumen Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.03(-17.6%) |
| 2024 | -1.25(-64.2%) |
| Date | Value |
|---|---|
| 2023 | -3.49(+71.9%) |
| 2022 | -2.03(-73.7%) |
| 2021 | -7.73 |
FAQ
- What is Acumen Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
- What is ABOS EV/EBITDA year-to-date change?
- What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
What is Acumen Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of ABOS is -1.03
What is the all time high EV/EBITDA for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high EV/EBITDA is -0.23
What is ABOS EV/EBITDA year-to-date change?
Acumen Pharmaceuticals EV/EBITDA has changed by +0.22 (+17.60%) since the beginning of the year
What is Acumen Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, ABOS EV/EBITDA has changed by +1.92 (+65.08%)